Human Amniotic Mesenchymal Stem Cell-Conditioned Medium Inhibited LPS-Induced Cell Injury and Inflammation by Modulating CD14/TLR4-Mediated Signaling Pathway in Monocytes

Researchers found that conditioned medium of human amniotic mesenchymal stem cells treatment suppressed lipopolysaccharide-induced activation of MAPK and NF-κB pathways by inhibiting CD14/TLR4 in THP-1 cells.